SuperworthJourney Medical shares outstanding DERM
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 27.5M
- On a year earlier
- +18.0%
- more shares
Journey Medical had 27.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 18.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 27.1M | +27% |
| FY2024 | 21.3M | +14% |
| FY2023 | 18.7M | +5% |
| FY2022 | 17.7M | +34% |
| FY2021 | 13.2M | +22% |
| FY2020 | 10.9M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 27.5M | +18% | |
| Q1 FY26 | 27.3M | +21% | |
| Q4 FY25 | 27.1M | +27% | |
| Q3 FY25 | 25M | +22% | |
| Q2 FY25 | 23.3M | +16% | |
| Q1 FY25 | 22.6M | +14% | |
| Q4 FY24 | 21.3M | +14% | |
| Q3 FY24 | 20.5M | −2% | |
| Q2 FY24 | 20M | +11% | |
| Q1 FY24 | 19.8M | +11% | |
| Q4 FY23 | 18.7M | +5% | |
| Q3 FY23 | 21M | +19% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Journey Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.